It is thus likely that deficiency in meprin B and heterodimeric meprin A (α-β) tilts the balance toward anti-inflammation activities driven by homomeric meprin A (α-α) and thus protects from injury in diabetic kidney disease. The gene discussed is MEP1B; the disease is diabetic kidney disease.